Strs Ohio Assembly Biosciences, Inc. Transaction History

Strs Ohio

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$3.8 - $4.56 $138,320 - $165,984	-36,400 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$4.87 - $17.29 $177,268 - $629,356	36,400 New	36,400 $220,000
Q4 2018 Jan 23, 2019	SELL	$19.05 - $36.45 $152,400 - $291,600	-8,000 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$34.41 - $44.23 $268,398 - $344,994	-7,800 Reduced 49.37%	8,000 $297,000
Q2 2018 Aug 06, 2018	BUY	$39.21 - $50.29 $54,894 - $70,406	1,400 Added 9.72%	15,800 $619,000

Q1 2018 Apr 20, 2018	SELL	$41.7 - $64.16 $187,650 - $288,720	-4,500 Reduced 23.81%	14,400 $707,000
Q4 2017 Jan 23, 2018	SELL	$28.58 - $49.91 $108,604 - $189,658	-3,800 Reduced 16.74%	18,900 $855,000
Q3 2017 Oct 23, 2017	BUY	$23.08 - $34.92 $523,915 - $792,684	22,700	22,700 $792,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.